An Unexpected FLNC Phenotype: Expanding the Clinical Spectrum or a Second-Hit Disease Mechanism?

Mayo Clin Proc. 2019 May;94(5):751-753. doi: 10.1016/j.mayocp.2019.03.015.

Authors

Jodie Ingles¹, Christopher Semsarian²

Affiliations

¹ Agnes Ginges Centre for Molecular Cardiology at Centenary Institute, Faculty of Medicine and Health, Department of Cardiology, Royal Prince Alfred Hospital, Sydney, Australia.
² Agnes Ginges Centre for Molecular Cardiology at Centenary Institute, Faculty of Medicine and Health, Department of Cardiology, Royal Prince Alfred Hospital, Sydney, Australia. Electronic address: c.semsarian@centenary.org.au.

PMID: 31054602
DOI: 10.1016/j.mayocp.2019.03.015

No abstract available

Publication types

Editorial
Comment

MeSH terms

Arrhythmias, Cardiac
Filamins
Humans
Mitral Valve Prolapse*
Phenotype

Substances

FLNC protein, human
Filamins